產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CCL27抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CCL27抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CCL27
Cat. Number:
Anti-CCL27抗體KL-2484R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is one of several CCAnti-CCL27抗體 cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene is chemotactic for skin-associated memory T lymphocytes. This cytokine may also play a role in mediating homing of lymphocytes to cutaneous sites. It specifically binds to chemokine receptor Anti-CCL27抗體10 (CCR10). Studies of a similar murine protein indicate that these protein-receptor interactions have a pivotal role in T cell-mediated skin inflammation. [provided by RefSeq].
Also known as:
ALP; CTACK; C-C motif chemokine Anti-CCL27抗體27; CC chemokine ILC; Ccl27; CTAK; Cutaneous T cell attracting chemokine; Cutaneous T-cell-attracting chemokine; ESkine; IL 11 R alpha locus chemokine; IL-11 R-alpha-locus chemokine; PESKY; SCYA27; Skinkine; Small inducible cytokine A27; Small-inducible cytokine A27.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from mouse CCL27 N-terminus.
●
Predicted Molecular Weight: 19kDa.Anti-CCL27抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-CCL27抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-CCL27抗體 must be determined by the end user.
kl041Mu01 過(guò)氧化物酶體增殖物激活受體δ(Pklδ)多克隆抗體 Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Delta (Pkld)
kl064Ra01 白介素24(IL24)多克隆抗體 Polyclonal Antibody to Interleukin 24 (IL24)
kl124Hu01 Smad同源物2(Smad2)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 2 (Smad2)
kl146Mu01 Ⅷ型膠原α1(COL8α1)多克隆抗體 Polyclonal Antibody to Collagen Type VIII Alpha 1 (COL8a1)
kl146Ra01 Ⅷ型膠原α1(COL8α1)多克隆抗體 Polyclonal Antibody to Collagen Type VIII Alpha 1 (COL8a1)
kl166Hu01 Ⅱ類主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl166Si01 Ⅱ類主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl179Ge01 伴刀豆球蛋白A(ConA)多克隆抗體 Polyclonal Antibody to Concanavalin A (ConA)
kl288Ra01 同種異體移植炎癥因子1(AIF1)多克隆抗體 Polyclonal Antibody to Allograft Inflammatory Factor 1 (AIF1)
kl299Po01 載脂蛋白M(APOM)多克隆抗體 Polyclonal Antibody to Apolipoprotein M (APOM)
kl340Bo01 胱天蛋白酶6(CASP6)多克隆抗體 Polyclonal Antibody to Caskle 6 (CASP6)
kl472Mu01 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體 Polyclonal Antibody to Fibulin 1 (FBLN1)
kl472Ra01 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體 Polyclonal Antibody to Fibulin 1 (FBLN1)
kl477Mu01 纖維蛋白原γ(FGγ)多克隆抗體 Polyclonal Antibody to Fibrinogen Gamma (FGg)
kl538Mu01 胰島細(xì)胞自身抗原1(ICA1)多克隆抗體 Polyclonal Antibody to Islet Cell Autoantigen 1 (ICA1)
kl775Ra01 絡(luò)絲蛋白(RL)多克隆抗體 Polyclonal Antibody to Reelin (RL)
kl845Mu01 腎酶(RNLS)多克隆抗體 Polyclonal Antibody to Renalase (RNLS)
kl904Mu01 谷氨酸脫羧酶1(GAD1)多克隆抗體 Polyclonal Antibody to Glutamate Decarboxylase 1, Brain (GAD1)
kl945Cp01 褪黑素受體1A(MTNR1A)多克隆抗體 Polyclonal Antibody to Melatonin Receptor 1A (MTNR1A)
kl977Ov01 癌胚抗原相關(guān)細(xì)胞粘附分子1(CEACAM1)多克隆抗體 Polyclonal Antibody to Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1)
kl978Ra01 癌胚抗原相關(guān)細(xì)胞粘附分子3(CEACAM3)多克隆抗體 Polyclonal Antibody to Carcinoembryonic Antigen Related Cell Adhesion Molecule 3 (CEACAM3)
